BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34944589)

  • 1.
    Hafezi F; Jaxel L; Lemaire M; Turner JD; Perez-Bercoff D
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944589
    [No Abstract]   [Full Text] [Related]  

  • 2. Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
    Panebianco F; Nikitski AV; Nikiforova MN; Nikiforov YE
    Cancer Med; 2019 Oct; 8(13):5831-5839. PubMed ID: 31408918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E4F1 and ZNF148 are transcriptional activators of the -57A > C and wild-type
    Chua BH; Zaal Anuar N; Ferry L; Domrane C; Wittek A; Mukundan VT; Jha S; Butter F; Tenen DG; Defossez PA; Kappei D
    Genome Res; 2023 Nov; 33(11):1893-905. PubMed ID: 37918959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutations and prognosis in solitary fibrous tumor.
    Bahrami A; Lee S; Schaefer IM; Boland JM; Patton KT; Pounds S; Fletcher CD
    Mod Pathol; 2016 Dec; 29(12):1511-1522. PubMed ID: 27562490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT Promoter Mutations and Telomerase in Melanoma.
    Guo Y; Chen Y; Zhang L; Ma L; Jiang K; Yao G; Zhu L
    J Oncol; 2022; 2022():6300329. PubMed ID: 35903534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.
    Akıncılar SC; Khattar E; Boon PL; Unal B; Fullwood MJ; Tergaonkar V
    Cancer Discov; 2016 Nov; 6(11):1276-1291. PubMed ID: 27650951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).
    Campanella NC; Celestino R; Pestana A; Scapulatempo-Neto C; de Oliveira AT; Brito MJ; Gouveia A; Lopes JM; Guimarães DP; Soares P; Reis RM
    Eur J Hum Genet; 2015 Jun; 23(6):877-9. PubMed ID: 25248398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Occurrence of Hotspot Point Mutation and Novel Deletion Mutation of
    Han J; Oh YL; Kim JS
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33375021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.
    Roh MR; Park KH; Chung KY; Shin SJ; Rha SY; Tsao H
    Am J Cancer Res; 2017; 7(1):134-138. PubMed ID: 28123854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of TERT promoter mutations in primary tumors of the liver.
    Quaas A; Oldopp T; Tharun L; Klingenfeld C; Krech T; Sauter G; Grob TJ
    Virchows Arch; 2014 Dec; 465(6):673-7. PubMed ID: 25267585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
    Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
    Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patients.
    Manrique-Silva E; David ME; Maider AM; García-Casado Z; Moro R; Requena C; Través V; Virós A; Kumar R; Nagore E
    Pigment Cell Melanoma Res; 2024 May; 37(3):343-351. PubMed ID: 38153178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.
    Del Bianco P; Stagni C; Giunco S; Fabozzi A; Elefanti L; Pellegrini S; Vecchiato A; Pigozzo J; Zamuner C; De Rossi A; De Nicolo A; Menin C
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.
    Kim YJ; Yoo JE; Jeon Y; Chong JU; Choi GH; Song DG; Jung SH; Oh BK; Park YN
    Int J Cancer; 2018 Dec; 143(12):3155-3168. PubMed ID: 29987895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.
    de Biase D; Gandolfi G; Ragazzi M; Eszlinger M; Sancisi V; Gugnoni M; Visani M; Pession A; Casadei G; Durante C; Costante G; Bruno R; Torlontano M; Paschke R; Filetti S; Piana S; Frasoldati A; Tallini G; Ciarrocchi A
    Thyroid; 2015 Sep; 25(9):1013-9. PubMed ID: 26148423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
    Wu RC; Ayhan A; Maeda D; Kim KR; Clarke BA; Shaw P; Chui MH; Rosen B; Shih IeM; Wang TL
    J Pathol; 2014 Mar; 232(4):473-81. PubMed ID: 24338723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
    Landa I; Ganly I; Chan TA; Mitsutake N; Matsuse M; Ibrahimpasic T; Ghossein RA; Fagin JA
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1562-6. PubMed ID: 23833040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avian Leukosis Virus Activation of an Antisense RNA Upstream of TERT in B-Cell Lymphomas.
    Nehyba J; Malhotra S; Winans S; O'Hare TH; Justice J; Beemon K
    J Virol; 2016 Oct; 90(20):9509-17. PubMed ID: 27512065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
    Arita H; Narita Y; Fukushima S; Tateishi K; Matsushita Y; Yoshida A; Miyakita Y; Ohno M; Collins VP; Kawahara N; Shibui S; Ichimura K
    Acta Neuropathol; 2013 Aug; 126(2):267-76. PubMed ID: 23764841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.
    Pierini T; Nardelli C; Lema Fernandez AG; Pierini V; Pellanera F; Nofrini V; Gorello P; Moretti M; Arniani S; Roti G; Giovenali P; Lupattelli M; Metro G; Molica C; Castrioto C; Corinaldesi R; Laurenti ME; Ascani S; Mecucci C; La Starza R
    Acta Neuropathol Commun; 2020 Aug; 8(1):145. PubMed ID: 32843091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.